ストックスクリーナーアプリを入手
144.05
1.05%
-1.53
アフターアワーズ：
144.98
0.93
+0.65%
前日終値:
$145.58
開ける：
$146.7
24時間の取引高:
1.03M
Relative Volume:
0.69
時価総額：
$11.63B
収益：
$8.19B
当期純損益:
$758.19M
株価収益率:
15.69
EPS:
9.18
ネットキャッシュフロー:
$1.06B
1週間 パフォーマンス:
-4.30%
1か月 パフォーマンス:
-2.03%
6か月 パフォーマンス:
-28.85%
1年 パフォーマンス:
-58.39%
1日の値動き範囲:
$142.69
$148.83
1週間の範囲:
$142.69
$155.90
52週間の値動き範囲:
$125.10
$345.86
Icon Plc Stock (ICLR) Company Profile
ICLR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
144.05 | 12.05B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
416.31 | 160.88B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
193.30 | 143.62B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.57 | 43.33B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.43 | 34.37B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.64 | 28.45B | 15.50B | 1.33B | 2.16B | 7.34 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-04-14 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-03-21 | ダウングレード | Goldman | Buy → Neutral |
| 2025-01-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-10-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 開始されました | Redburn Atlantic | Neutral |
| 2024-09-18 | 開始されました | Leerink Partners | Outperform |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2023-12-15 | 開始されました | Truist | Buy |
| 2023-09-13 | 開始されました | TD Cowen | Outperform |
| 2023-01-17 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-01-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-11-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-09-07 | 開始されました | UBS | Buy |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2021-09-27 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-14 | 開始されました | Citigroup | Neutral |
| 2021-04-13 | 再開されました | BofA Securities | Neutral |
| 2021-04-01 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 開始されました | Barclays | Equal Weight |
| 2021-03-01 | アップグレード | UBS | Neutral → Buy |
| 2021-02-26 | アップグレード | Truist | Hold → Buy |
| 2020-07-24 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-04-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 開始されました | Deutsche Bank | Hold |
| 2020-01-27 | ダウングレード | SunTrust | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-09-23 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | アップグレード | UBS | Sell → Neutral |
| 2019-01-25 | アップグレード | Mizuho | Neutral → Buy |
| 2018-10-26 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 開始されました | UBS | Sell |
| 2018-04-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 繰り返されました | Mizuho | Neutral |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
| 2017-10-27 | 繰り返されました | Barclays | Equal Weight |
| 2017-09-11 | 開始されました | BofA/Merrill | Buy |
| 2017-07-31 | アップグレード | SunTrust | Hold → Buy |
| 2017-07-27 | 繰り返されました | Mizuho | Neutral |
| 2017-06-29 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Icon Plc (ICLR) 最新ニュース
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
ICON Dominates Phase 1 Clinical Trials: Outperforms All Major CROs in 17 Key Metrics - Stock Titan
Do You Believe in the Upside Potential of ICON PLC (ICLR)? - Insider Monkey
Clinical Trial Investigative Site Network Market Top Players - openPR.com
Launch Your Career as a Life Science Intern at ICON, Apply Now! - BioTecNika
Icon (ICLR) Gets a Buy from Leerink Partners - The Globe and Mail
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $187 - 富途牛牛
ICON plc stock price target lowered to $187 at Truist Securities - Investing.com Nigeria
ICON plc stock price target lowered to $187 at Truist Securities By Investing.com - Investing.com South Africa
WCM Investment Management, LLC Significantly Reduces Stake in Icon PLC - GuruFocus
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability - 01net
Should You Hold ICON PLC (ICLR)? - MSN
Will ICON PLC (ICLR) Benefit from R&D Spending? - Insider Monkey
Barclays Sticks to Their Hold Rating for Icon (ICLR) - The Globe and Mail
ICON plc Schedules Q2 2025 Earnings Call - TipRanks
ICON plc Schedules Second Quarter 2025 Earnings Conference Call - Business Wire
ICON plc Reports Strong Interim Financial Results for Early 2025 - TipRanks
Medical Device Regulatory Affairs Market Top PlayersICON, - openPR.com
ICON plc Announces 2025 AGM and Key Resolutions - TipRanks
Icon PLC (ICLR) Shares Up 3.47% on Jun 6 - GuruFocus
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.
ICON Public Limited (NASDAQ:ICLR) Short Interest Up 25.4% in May - Defense World
Icon PLC (ICLR) Stock Price Up 4.49% on Jun 4 - GuruFocus
ICON at William Blair Conference: Strategic Focus Amid Challenges - Investing.com
ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review - mx.advfn.com
Here's Why You Should Retain ICLR Stock in Your Portfolio Now - TradingView
Icon PLC (ICLR) Down 9.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
ICON plc to Present at the William Blair 45th Annual Growth Stoc - GuruFocus
ICON plc to Present at Annual Growth Stock Conference By Investing.com - Investing.com South Africa
ICLR December 2026 Options Begin Trading - Nasdaq
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference - BioSpace
ICON plc to Present at Annual Growth Stock Conference - Investing.com
ICON plc to Present at William Blair Growth Stock Conference - TipRanks
ICON’s SWOT analysis: cro stock faces headwinds amid potential rebound - Investing.com
ICON Life Science Internship For BSc & MSc – Applications Closing Soon! Hurry! - BioTecNika
Redburn Atlantic Adjusts Icon (ICLR) Price Target Amid Market Uncertainty | ICLR Stock News - GuruFocus
ICON Plc stock hits 52-week low at $127.51 amid market challenges By Investing.com - Investing.com South Africa
ICON Plc stock hits 52-week low at $127.51 amid market challenges - Investing.com Nigeria
ICON releases its ICON Cares 2024 Report | ICLR Stock News - GuruFocus
ICON releases its ICON Cares 2024 Report - Silicon Canals
ICON Releases ICON Cares 2024 Report Highlighting ESG Achievements - TipRanks
ICON Leads CRO Industry in Sustainability: Achieves 70% GHG Reduction and TIME Recognition - Stock Titan
ICON holds lead as most active CRO, GlobalData finds - The Pharma Letter
Icon (ICLR) Maintains Outperform Rating Amid Price Target Adjustment | ICLR Stock News - GuruFocus
Icon (ICLR) Price Target Reduced by Mizuho to $173 | ICLR Stock News - GuruFocus
Icon Plc (ICLR) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
0.97%
大文字化:
|
ボリューム (24 時間):